
Olema Pharmaceuticals is a biotechnology business based in the US. Olema Pharmaceuticals shares (OLMA) are listed on the NASDAQ and all prices are listed in US Dollars. Olema Pharmaceuticals employs 73 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Olema Pharmaceuticals stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – OLMA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Olema Pharmaceuticals stock price (NASDAQ: OLMA)
Use our graph to track the performance of OLMA stocks over time.Olema Pharmaceuticals shares at a glance
Latest market close | $4.74 |
---|---|
52-week range | $2.00 - $7.41 |
50-day moving average | $3.02 |
200-day moving average | $3.47 |
Wall St. target price | $13.25 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.99 |
Buy Olema Pharmaceuticals stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Olema Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Olema Pharmaceuticals price performance over time
Historical closes compared with the close of $4.74 from 2023-01-26
1 week (2023-01-20) | 1.94% |
---|---|
1 month (2022-12-27) | 84.44% |
3 months (2022-10-27) | 29.86% |
6 months (2022-07-27) | -5.39% |
1 year (2022-01-27) | -17.42% |
---|---|
2 years (2021-01-27) | -89.71% |
3 years (2020-01-23) | N/A |
5 years (2018-01-23) | N/A |
Olema Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -23.42% |
Return on equity TTM | -38.66% |
Profit margin | 0% |
Book value | $5.43 |
Market capitalisation | $200.7 million |
TTM: trailing 12 months
Olema Pharmaceuticals share dividends
We're not expecting Olema Pharmaceuticals to pay a dividend over the next 12 months.
Olema Pharmaceuticals share price volatility
Over the last 12 months, Olema Pharmaceuticals's shares have ranged in value from as little as $2 up to $7.41. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Olema Pharmaceuticals's is 1.6012. This would suggest that Olema Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Olema Pharmaceuticals's beta into context you can compare it against those of similar companies.
- Puma Biotechnology (PBYI.US): 1.0094
- Xenetic Biosciences (XBIO.US): 2.2815
- Inovio Pharmaceuticals (INO.US): 1.0684
- Oncorus Inc (ONCR.US): 2.4269
Olema Pharmaceuticals overview
Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals in the news
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference
Frequently asked questions
What percentage of Olema Pharmaceuticals is owned by insiders or institutions?Currently 6.817% of Olema Pharmaceuticals shares are held by insiders and 84.457% by institutions. How many people work for Olema Pharmaceuticals?
Latest data suggests 73 work at Olema Pharmaceuticals. When does the fiscal year end for Olema Pharmaceuticals?
Olema Pharmaceuticals's fiscal year ends in December. Where is Olema Pharmaceuticals based?
Olema Pharmaceuticals's address is: 512 2nd Street, San Francisco, CA, United States, 94107 What is Olema Pharmaceuticals's ISIN number?
Olema Pharmaceuticals's international securities identification number is: US68062P1066
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert